Optimizing Behavioral Healthcare Delivery Through Technology

The goal of this randomized controlled clinical trial is to determine the feasibility, acceptability, and preliminary efficacy of an artificial intelligence platform )שׁ( for behavioral health in facilitating better clinical outcomes for adult patients receiving outpatient therapy.The main question[s] it aims to answer are:whether an AI platform designed for behavioral healthcare would be feasible and acceptable to patients and therapists.whether the depression and anxiety outcomes of adults receiving outpatient cognitive-behavioral therapy (CBT) in a community-based clinic would be superior among patients whose therapists used an AI-based platform to support clinical decision making and administrative tasks compared to patients receiving treatment-as-usual (TAU).Participants will receive CBT for depression or anxiety and complete standardized assessments. Participants will be followed for the first two months of therapy.

Inclusion Criteria:Older than 18 years old.Presenting for an outpatient CBT for a depressive or anxiety disorder.Exclusion Criteria:Age <18.individuals who are medically unstable for outpatient treatment.a severe mental health condition that might interfere with treatment compliance (e.g., psychotic depression, psychosis, active substance dependence).